Understanding Chemotherapy-Associated Cognitive Decline: A Review of “Chemobrain”
A review of what researchers are finding about “chemobrain,” a common adverse effect experienced by patients receiving chemotherapy for cancer.
All articles by John Schieszer
Telehealth Ushering in a New Era in Cancer Care
Nurses at the forefront of telehealth practices share their views on how technology is expanding the reach of clinicians, improving cancer care for patients, and the barriers yet to be overcome.
Comparison Study Shows Predictive Value for CSCC of the Head and Neck of BWH vs AJCC 8
A team of researchers sought to determine if BWH Tumor Classification System classified tumors more accurately than AJCC 8, and their sensitivity and specificity for predicting poor outcomes.
Nurses’ Guide to Managing Symptoms of Myeloproliferative Neoplasms
Oncology nurses discuss the importance of ongoing education on the treatments, symptoms, and available information on MPNs for patients, and oncology nurses.
Dermatology Life Quality Index Valid for Assessing Radiodermatitis in Breast Cancer Patients
A pilot study revealed the effectiveness of the DLQI in assessing quality of life measures in women with breast cancer treatment-related radiodermatitis.
Risk for VTE Persists Over the Long Term for Survivors of Childhood Cancers
These study results illustrate a need to educate survivors of childhood cancers on an ongoing potential risk for venous thromboembolism (VTE) beyond 5 years postdiagnosis.
Prostate Cancer ADT Found to Increase Depression Risk
Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.
A Call for Better Use of Personal Protective Equipment Among Nurses
A randomized trial sought to measure the effect of educational modules on nurse use of personal protection equipment when handling and/or administering chemotherapy.
Adverse Events in Randomized Clinical Trials for Targeted Therapies High in Placebo Groups
Researchers conducted a meta-analysis to determine the incidence of adverse events among patients assigned to placebo-receiving groups in randomized clinical trials.
Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer
In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.
Next post in Head and Neck Cancer
